These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10579828)

  • 41. Evaluation of brain penetration of CCK-B antagonists.
    Dubroeucq MC; Guyon C; Manfré F; Capet M; Barreau M; Bertrand P; Jeantaud B; Doble A; Blanchard JC
    Ann N Y Acad Sci; 1994 Mar; 713():377-9. PubMed ID: 8185193
    [No Abstract]   [Full Text] [Related]  

  • 42. Cholecystokinin antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors.
    Kerwin JF; Wagenaar F; Kopecka H; Lin CW; Miller T; Witte D; Stashko M; Nadzan AM
    J Med Chem; 1991 Dec; 34(12):3350-9. PubMed ID: 1766000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Asp32-replacement tetrapeptide analogues as potent and selective CCK-A agonists.
    Elliott RL; Kopecka H; Tufano MD; Shue YK; Gauri AJ; Lin CW; Bianchi BR; Miller TR; Witte DG; Stashko MA
    J Med Chem; 1994 May; 37(11):1562-8. PubMed ID: 8201590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes.
    Kuntz E; Pinget M; Damgé C
    Eur J Pharmacol; 2002 Jul; 448(2-3):253-61. PubMed ID: 12144949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
    Galas MC; Bernad N; Martinez J
    Eur J Pharmacol; 1992 May; 226(1):35-41. PubMed ID: 1327841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
    Bellier B; Da Nascimento S; Meudal H; Gincel E; Roques BP; Garbay C
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1419-24. PubMed ID: 9871777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
    Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
    Lignon MF; Bernad N; Martinez J
    Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
    Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D
    J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.
    Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct demonstration of three different states of the pancreatic cholecystokinin receptor.
    Talkad VD; Fortune KP; Pollo DA; Shah GN; Wank SA; Gardner JD
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1868-72. PubMed ID: 8127897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationally designed "dipeptoid" analogues of CCK. A Free-Wilson/Fujita-Ban analysis of some alpha-methyltryptophan derivatives as CCK-B antagonists.
    Higginbottom M; Kneen C; Ratcliffe GS
    J Med Chem; 1992 May; 35(9):1572-7. PubMed ID: 1578483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonists.
    McDonald IM; Dunstone DJ; Kalindjian SB; Linney ID; Low CM; Pether MJ; Steel KI; Tozer MJ; Vinter JG
    J Med Chem; 2000 Sep; 43(19):3518-29. PubMed ID: 11000006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.